カテゴリ： MarketLine, イギリス, 企業調査

Endava Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：Endava Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C8939
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：32
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：技術・通信
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Endava Limited – Strategy, SWOT and Corporate Finance Report
Summary

Endava Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Endava Limited (Endava) is a provider of IT services based in the UK. The company offers application development and management, digital media, testing, infrastructure management and cloud services. Endava’s testing services include managed testing services, test automation, performance testing, agile testing and mobile testing. It also provides 24/7 technical support for business critical application and digital services. Endava provides its services to banking and payments, insurance, retail, consumer goods, telecommunications and travel and media, technology and publishing sectors. The company conducts business operations through a network of offices in the UK, the US, Germany, Romania, Moldova, Serbia and Macedonia. Endava is headquartered in London, England, the UK.

Scope

- Detailed information on Endava Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Endava Limited in the form of a SWOT analysis
- An in-depth view of the business model of Endava Limited including a breakdown and examination of key business segments
- Intelligence on Endava Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Endava Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Endava Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Endava Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Endava Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Endava Limited: Company Overview 9
Endava Limited: Overview and Key Facts 9
Endava Limited: Overview 9
Endava Limited: Key Facts 9
Endava Limited: Key Employees 10
Endava Limited: Key Employee Biographies 11
Endava Limited: Major Products and Services 12
Endava Limited: Company History 13
Endava Limited: Management Statement 14
Endava Limited: Locations and Subsidiaries 15
Endava Limited: Key Competitors 16
Endava Limited: Company Analysis 17
Endava Limited: Business Description 17
Endava Limited: SWOT Analysis 18
Endava Limited: SWOT Overview 18
Endava Limited: Strengths 18
Endava Limited: Weaknesses 19
Endava Limited: Opportunities 19
Endava Limited: Threats 19
Endava Limited: Corporate Financial Deals Activity 21
Endava Limited: Financial Deals Overview 21
Endava Limited: Top Deals 2014 – 2018YTD* 23
Endava Limited: Advisors 24
Endava Limited: Top Legal Advisors 24
Endava Limited: Top Financial Advisors 24
Endava Limited: Mergers and Acquisitions 25
Endava Limited: Capital Raising 26
Endava Limited: Recent Developments 27
Endava Limited: News and Events Summary 27
Endava Limited: Business Expansion 27
Endava Limited: Corporate Governance 28
Endava Limited: Financial Deals 28
Endava Limited: Financial Performance 29
Endava Limited: Strategy and Operations 29
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: Endava Limited: Key Facts
Table 2: Endava Limited: Key Employees
Table 3: Endava Limited: Company History
Table 4: Endava Limited: Locations and Subsidiaries
Table 5: Endava Limited: Key Competitors
Table 6: Endava Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Endava Limited: M&A Activity by Geography (TTM*)
Table 8: Endava Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Endava Limited: Top Deals 2014 - 2018YTD*
Table 10: Endava Limited: Legal Advisor Ranking by Value (US$m)
Table 11: Endava Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Endava Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Endava Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Endava Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Endava Limited: News and Events Summary
Table 16: Endava Limited: Business Expansion
Table 17: Endava Limited: Corporate Governance
Table 18: Endava Limited: Financial Deals
Table 19: Endava Limited: Financial Performance
Table 20: Endava Limited: Strategy and Operations

List of Figures
Figure 1: Endava Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Endava Limited: M&A Activity by Geography (TTM*)
Figure 3: Endava Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Endava Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Endava Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Endava Limited: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Endava Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Western Areas Limited：企業の戦略・SWOT・財務情報
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Revolution Lighting Technologies Inc (RVLT)：企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • General Electric Company：戦略・SWOT・企業財務分析
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bounty Oil & Gas NL (BUY)：企業の財務・戦略的SWOT分析
    Bounty Oil & Gas NL (BUY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cyprotex Ltd-医療機器分野：企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • Clean TeQ Holdings Ltd (CLQ)：企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Immunomedics Inc (IMMU)-医療機器分野：企業M&A・提携分析
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and automimmune disorders. The company’s portfolio of antibody-drug conjugates are aimed to sp …
  • Tzamal Medical Group Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equi …
  • SINTX Technologies Inc (SINT)：企業の財務・戦略的SWOT分析
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Energy Development Corp (EDC)：電力：M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • European Investment Bank：企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Foamix Pharmaceuticals Ltd (FOMX)：企業の財務・戦略的SWOT分析
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • TFS Financial Corporation：企業の戦略・SWOT・財務情報
    TFS Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Temasek Holdings (Private) Ltd：企業のM&A・事業提携・投資動向
    Temasek Holdings (Private) Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Temasek Holdings (Private) Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Twenty-First Century Fox Inc. (FOXA)：企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Addvalue Technologies Limited (A31)：企業の財務・戦略的SWOT分析
    Addvalue Technologies Limited (A31) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tatung Co. Ltd. (2371)：企業の財務・戦略的SWOT分析
    Summary Tatung Co. Ltd. (Tatung) is an electronic product manufacturer that designs, manufactures, distributes and sells digital consumer products. The company operates through its business group such as power, consumer and system solution group. Its power business group provides transformers, switc …
  • MAPFRE RE, Compania de Reaseguros S.A.：企業の戦略・SWOT・財務情報
    MAPFRE RE, Compania de Reaseguros S.A. - Strategy, SWOT and Corporate Finance Report Summary MAPFRE RE, Compania de Reaseguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • IPCA Laboratories Ltd (IPCALAB)：企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • Impel NeuroPharma Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delive …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆